2020
Exploring response inhibition and error monitoring in obsessive-compulsive disorder
Silveira V, Frydman I, Fontenelle L, Mattos P, de Oliveira-Souza R, Moll J, Hoexter M, Miguel E, McLaughlin N, Shephard E, Batistuzzo M. Exploring response inhibition and error monitoring in obsessive-compulsive disorder. Journal Of Psychiatric Research 2020, 126: 26-33. PMID: 32413597, PMCID: PMC7313630, DOI: 10.1016/j.jpsychires.2020.04.002.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderError monitoringNon-psychiatric controlsResponse inhibitionStop-signal taskBehavioral evidenceEffect sizeRecent neuroimaging workImpaired response inhibitionPreliminary behavioral evidenceMedium effect sizeLarge effect sizesNeuroimaging workBehavioral measuresSmall effect sizesPossible moderatorsOCD severitySymptomatic patientsClinical factorsEM performancePossible associationDifferential effects
2012
Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
Valerio C, Diniz J, Fossaluza V, de Mathis M, Belotto-Silva C, Joaquim M, Filho E, Shavitt R. Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states? Journal Of Affective Disorders 2012, 139: 187-192. PMID: 22455835, DOI: 10.1016/j.jad.2012.02.002.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderPsychiatric comorbidityTreatment responseOCD treatment responseTic disordersOCD treatmentAnxiety disordersOCD patientsNon-blinded studyAdditional psychiatric disordersCertain comorbid disordersPrimary obsessive-compulsive disorderCommon comorbiditiesAdult patientsComorbid conditionsComorbid depressiveChronic conditionsMajor depressionTreatment protocolComorbiditiesComorbid disordersPsychiatric disordersDisorders ProgramConventional treatmentPossible association